REGENXBIO Inc.
RGNX· Nasdaq
RGNXREGENXBIO Inc.
Source filing unavailable
| Metric | Q1 2015 | Q1 2014 |
|---|---|---|
| Revenue | $644.00K | $2.94M |
| Net Income | -$4.01M | $795.00K |
| EPS Diluted | -$0.94 | $0.08 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
REGENXBIO Inc. · CIK 1590877 · Engraved from SEC EDGAR
